Advertisement

Topics

Axiom Biotechnologies Incorporated Company Profile

04:05 EDT 17th October 2017 | BioPortfolio

Axiom Biotechnologies are an emerging biopharmaceutical company focused on the rapid discovery and development of more effective and safer drugs through the use of our proprietary human cell-based Physiogenomics technology. The technology integrates their Human Cell Bank, containing over 100 human cell lines representing all the major tissues of the human body, and their proprietary cell assay technologies. By using human cell lines, Axiom accurately represent the functions of genes and directly determine their validity as drug targets. Axiom Biotechnologies are currently applying this drug discovery approach through their internal drug discovery programs in the fields of cancer, acid reflux disease and obesity, as well as through our strategic collaborations with other pharmaceutical and biotechnology companies.

Location

3550 General Atomics Court
San Diego
CA
92121-1194
United States of America

Contact

Phone: (858) 455-4500
Fax: (858) 455-4501
Email: bobl@axiombio.com


News Articles [94 Associated News Articles listed on BioPortfolio]

Axiom Real-Time Metrics Showcasing Fusion eClinical Suite at the Outsourcing in Clinical ...

TORONTO, ON--(Marketwired - June 22, 2017) -Axiom Real-Time Metrics, the premier provider of eClinical solutions and services to small to mid-sized life sciences Read more...

Axiom Real-Time Metrics Showcasing Fusion eClinical Suite at Outsourcing in Clinical Trials: ...

TORONTO, ON--(Marketwired - September 01, 2017) -Axiom Real-Time Metrics, the premier provider of eClinical solutions and services to small to mid-sized life sciences Read more...

DGAP-HV: Elanix Biotechnologies AG: -6-

DJ DGAP-HV: Elanix Biotechnologies AG: Bekanntmachung der Einberufung zur Hauptversammlung am 24.08.2017 in Berlin mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG Dow Jones hat von EQS/D....

DGAP-HV: Elanix Biotechnologies AG: -5-

DJ DGAP-HV: Elanix Biotechnologies AG: Bekanntmachung der Einberufung zur Hauptversammlung am 24.08.2017 in Berlin mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG Dow Jones hat von EQS/D....

DGAP-HV: Elanix Biotechnologies AG: -4-

DJ DGAP-HV: Elanix Biotechnologies AG: Bekanntmachung der Einberufung zur Hauptversammlung am 24.08.2017 in Berlin mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG Dow Jones hat von EQS/D....

DGAP-HV: Elanix Biotechnologies AG: -3-

DJ DGAP-HV: Elanix Biotechnologies AG: Bekanntmachung der Einberufung zur Hauptversammlung am 24.08.2017 in Berlin mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG Dow Jones hat von EQS/D....

DGAP-HV: Elanix Biotechnologies AG: -2-

DJ DGAP-HV: Elanix Biotechnologies AG: Bekanntmachung der Einberufung zur Hauptversammlung am 24.08.2017 in Berlin mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG Dow Jones hat von EQS/D....

Fujifilm Diosynth Biotechnologies opens new UK lab

Fujifilm Diosynth Biotechnologies has opened a $9m process development laboratory in Teeside, UK.

PubMed Articles [21 Associated PubMed Articles listed on BioPortfolio]

Sourdough-Based Biotechnologies for the Production of Gluten-Free Foods.

Sourdough fermentation, a traditional biotechnology for making leavened baked goods, was almost completely replaced by the use of baker's yeast and chemical leavening agents in the last century. Recen...

Optimization of protocols for Iberian red deer (Cervus elaphus hispanicus) sperm handling before sex sorting by flow cytometry.

Currently, sperm reproductive biotechnologies such as sex sorting and cryopreservation are undoubtedly valuable tools for improving the economic and biological efficiency of red deer production system...

Anomalous Metapopulation Dynamics on Scale-Free Networks.

We model transport of individuals across a heterogeneous scale-free network where a few weakly connected nodes exhibit heavy-tailed residence times. Using the empirical law of the axiom of cumulative ...

Is De-extinction Special?

I have been involved with the current interest in de-extinction since early 2012, nearly its beginning. I have given a lot of thought to the potential risks and benefits of de-extinction. But only rec...

Characterization of Copy Number Variation's Potential Role in Marek's Disease.

Marek's Disease (MD) is a highly contagious pathogenic and oncogenic disease primarily affecting chickens. Chicken Lines 63 and 72, as well as their recombinant congenic strains (RCS) with varied susc...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Clinical Efficacy and Safety of Axiom Worldwide DRX9000 Axial Decompression System for Treatment of Low Back Pain

This study will document efficacy and safety of the Axiom Worldwide DRX9000™ for treatment of low back pain (LBP) in a prospective, randomized, crossover, multicenter trial utilizing a ...

An Observational Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer (AXIOM)

This prospective observational study will evaluate the safety and efficacy of Xeloda (capecitabine) administered in monotherapy in patients with metastatic colorectal cancer. Patients will...

Companies [140 Associated Companies listed on BioPortfolio]

Axiom Biotechnologies Incorporated

Axiom Biotechnologies are an emerging biopharmaceutical company focused on the rapid discovery and development of more effective and safer drugs through the use of our proprietary human cell-based Phy...

AXIOM VENTURE PARTNERS,L.P

Axiom Venture Partners provides capital and strategic assistance to rapidly growing high technology companies.Axiom’s professionals bring substantial investing experience and industry expertise to t...

Axiom Resources

Axiom Resources provides staffing solutions to the Biotechnology and Pharmaceutical industries. Our specialties include Genomics, Bioinformatics, Proteomics and Microarrays. Our extensive experience i...

RAN Biotechnologies

Based in Beverly, MA, USA, RAN Biotechnologies, Inc., www.ranbiotechnologies.com, provides chemicals specially optimized for microfluidic and biotechnological applications. Partic...

Open Therapeutics

Open Therapeutics (http://OpenTherapeutics.org) is a crowdsourcing life science firm that creates and attracts therapeutic biotechnologies and crowdsources them for the global ...

More Information about "Axiom Biotechnologies Incorporated" on BioPortfolio

We have published hundreds of Axiom Biotechnologies Incorporated news stories on BioPortfolio along with dozens of Axiom Biotechnologies Incorporated Clinical Trials and PubMed Articles about Axiom Biotechnologies Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Axiom Biotechnologies Incorporated Companies in our database. You can also find out about relevant Axiom Biotechnologies Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record